You are here

Are All Stem Cells Equal in BPD?

A research team led by Sajit Augustine (Western University, Ontario, Canada) recently performed a systematic review and network meta‐analysis of preclinical studies testing stem cell‐based therapies in experimental neonatal lung injury in the hope of improving regenerative treatments for bronchopulmonary dysplasia (BPD), a common preterm birth complication. While this STEM CELLS Translational Medicine article highlights mesenchymal stem cell-based therapies as the most effective treatments, the authors underscore the lack of head‐to‐head comparisons and the existence of an unclear risk of bias.